-
Diagnostics World News | A team of researchers from Guy's and St Thomas' NHS Foundation Trust and Oxford Nanopore have shared a novel protocol for the rapid metagenomic characterization of DNA and RNA viruses. The workflow identified pathogens in a matter of hours.
Jun 22, 2022
-
Diagnostics World News | The pandemic has thrown a spotlight on the Emergency Use Authorization (EUA) process of the U.S. Food and Drug Administration (FDA) whereby the agency can quickly give companies temporary permission to market unapproved medical products or unapproved uses of approved ones. The FDA’s EUA power has been in place a long time, and many such authorizations—including diagnostics specific to the Ebola and Zika viruses—remain open many years after declaration of the public health emergency that invoked it, according to B. Melina Cimler, Ph.D., CEO and founder of PandiaDx, a consultancy specializing in regulatory matters surrounding in vitro diagnostics.
Jun 21, 2022
-
Diagnostics World News | Jorge Cardoso, a researcher at King’s College London and CTO at the London AI Centre, and NVIDIA have released 100,000 synthetic brain MRI images freely available to healthcare researchers. They believe the dataset will accelerate diagnosis and understanding of dementia, aging, or any sort of brain disease.
Jun 16, 2022
-
Diagnostics World News | A significantly heightened risk of breast cancer has two well-known culprits—mutations to the tumor suppressor genes BRCA1 and BRCA2—but more than 40% of the time they are black-box “variants of uncertain significance.” Using a new data-sharing innovation known as federated analysis, however, an international team of researchers has categorized 16 of these uncertain variants as benign or likely benign so their carriers may be able to have their clinical risk of disease managed properly and avoid the risk of invasive and irrevocable surgeries.
Jun 14, 2022
-
Diagnostics World News | Novel network analysis technology that uses only 10 minutes of resting state electrophysiological recordings has been shown to localize seizure onset brain regions and predict seizure outcomes in epilepsy patients.
Jun 8, 2022
-
Diagnostics World News | At the Bio-IT World Conference & Expo last month, several sessions explored ways AI is transforming oncology diagnosis, research, and care delivery. Speakers from the National Cancer Institute, Tempus Labs, The Ohio State University, IQVIA, Pangaea Data, University of Illinois Cancer Center, Stable Solutions and more discussed how far we’ve come, and where our next challenges lie.
Jun 7, 2022
-
Diagnostics World News | The U.S. Food and Drug Administration’s Center for Devices and Radiological Health this week announced that it will start accepting all non-COVID in vitro diagnostic pre-submissions starting June 1, 2022.
Jun 3, 2022
-
Diagnostics World News | Innovative Practices Award | Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and lengthy documents. That’s why the scientists at Guardant Health and Linguamatics, an IQVIA company, launched a real-world evidence database called GuardantINFORM. The platform was named one of the 2022 Bio-IT World Innovative Practices award winners.
Jun 2, 2022
-
Diagnostics World News | Crosscope and Farcast Bioscience created OrionAI–an artificially intelligent (AI) diagnostic assistant for tumor histological examination. Crosscope developed the AI-enabled digital pathology platform and proprietary algorithms, while Farscape Bioscience created the histoculture platform that preserves entire human tumor microenvironments. OrionAI increases diagnostic speed and lowers misdiagnosis rates of head and neck squamous cell carcinoma, a highly prevalent disease worldwide.
May 31, 2022
-
Diagnostics World | This week Illumina announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.
May 27, 2022
-
Diagnostics World News | An AI-based diagnostic histoculture platform preserves human tumor microenvironment; FUJIFILM partners with over 150 imaging centers across the United States; two multiplex respiratory virus tests enable rapid differentiation and detection; and more.
May 26, 2022
-
Diagnostics World News| Funding for pathology diagnostics, rapid DNA sequencing, AI-powered disease detection, and more.
May 25, 2022
-
Diagnostics World News | Electrical and computer engineers at Stevens Institute of Technology, together with clinical dermatology specialists at Hackensack University Medical Center (HUMC), are collaboratively developing a low-cost, handheld imaging device that provides laboratory-grade diagnoses of different types of skin cancer. It should be received as a welcome alternative to skin biopsies, about half of which are unnecessarily done for want of another method for differentiating benign from cancerous tissue.
May 19, 2022
-
Diagnostics World News | Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine, and Stavros Papadopoulos, TileDB, presented at Bio-IT World Conference & Expo about diagnostic whole-genome testing, newborn screening, treatment integration, and a single-platform multi-dimensional database.
May 18, 2022
-
Diagnostics World News| A first-of-its-kind microfluidic diagnostic device that eliminates the usual liquid handling steps could enable pathogen detection, as well as gene sequencing, outside of a lab setting involving a lot of equipment and personnel. The small, no-frills chip is being developed by electrical and computer engineers at the University of Minnesota Twin Cities.
May 17, 2022
-
Diagnostics World | A pioneering program of Geisinger Health System has returned clinically actionable results from exome sequencing to a record-breaking 3,400 individuals at increased risk for potentially life-threatening conditions such as hereditary breast and colon cancers, familial hypercholesterolemia (FH), and heart disease. The MyCode Community Health Initiative, enabled by a 2014 agreement with Regeneron Pharmaceuticals, draws from participants in a sizable DNA biobank who agree to the sequencing and results reporting.
May 11, 2022
-
Diagnostics World News | An interdisciplinary team of researchers at The Ohio State University (OSU) is creating a “new paradigm for personalized medicine” with a skin gas sensing device for monitoring metabolism and managing weight.
May 5, 2022
-
Diagnostics World News | Over the next few years, pharmacogenomics could start to become a standard component of clinical care to improve drug efficacy and avoid adverse responses when certain medicines are prescribed.
May 3, 2022
-
Diagnostics World | Funding for AI in disease detection and non-invasive brain diagnostics, immune-oncology cancer therapeutics, tissue therapeutics, and more.
Apr 29, 2022
-
Diagnostics World News | New genomics efforts in Brazil, HPV variant tests, COVID-19 virus and antibody tests, pre-term birth prediction by RNA profiling, metabolomics-based diagnostics, high-plex spatial imaging, blood-based glycoproteomics, new device for detecting mild cognitive impairment, and an award for rapid infection diagnostics.
Apr 28, 2022